Mr. Alan Ridgeway

Mr. Alan Ridgeway

Partner, Sprott Capital Partners

Alan Ridgeway has worked as a publishing research analyst for more than 10 years. Prior to joining Sprott Capital Partners he covered the Canadian healthcare sector at Scotiabank where he was ranked #1 by Greenwich Associates and #2 by Brendan Wood International. Prior to working in the capital markets, Mr. Ridgeway held a postdoctoral fellowship at Harvard Medical School where he performed cancer research. Mr. Ridgeway holds a PhD in Biochemistry from Western University, an MBA from Queen’s University, and is a CFA® Charterholder.